Irritable bowel syndrome (IBS) manifests as a heterogeneous clinical picture in terms of the type and severity of symptoms, affecting around 16% of the population. Diagnostically, IBS is a challenge for the physician, and drug therapy is often unsatisfactory for the patient – also due to false expectations.
This content is machine-translated. Please contact us if you need professional translation services.
Autoren
- Jens Dehn
Publikation
- GASTROENTEROLOGIE PRAXIS
Related Topics
You May Also Like
- Cardiovascular risk in IBD
Cause for concern?
- Microplastics in kidneys and urine
Life in plastic … is not fantastic
- Asthma and psyche
When fear makes you lose your breath
- COPD: Update for the primary care physician
Counteract exacerbations and improve quality of life
- Stroke
Not on the brain – the latest findings on strokes
- Atopic dermatitis: choice of systemic therapy option
“It’s always an individual weighing”.
- Do low carb diets harm the heart?
Keto diet associated with hypercholesterolemia and increased risk of ASCVD
- Cardiovascular events in CKD